{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:54:43Z","timestamp":1717235683292},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T00:00:00Z","timestamp":1159488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T00:00:00Z","timestamp":1159488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00280-006-0348-9","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T09:32:24Z","timestamp":1159435944000},"page":"61-67","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phase II trial of 10-EDAM in the treatment of metastatic breast cancer"],"prefix":"10.1007","volume":"60","author":[{"given":"Garth A.","family":"Beinart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Gonzalez-Angulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Broglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Frye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frankie Ann","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaji","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Booser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,29]]},"reference":[{"issue":"2","key":"348_CR1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics. CA Cancer J Clin 2006 56(2):106\u2013130","journal-title":"CA Cancer J Clin 2006"},{"issue":"Suppl 3","key":"348_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.10-90003-20","volume":"10","author":"J O\u2019Shaughnessy","year":"2005","unstructured":"O\u2019Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10(Suppl 3):20\u201329","journal-title":"Oncologist"},{"issue":"1","key":"348_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/cncr.11859","volume":"100","author":"SH Giordano","year":"2004","unstructured":"Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN (2004) Is breast cancer survival improving? Cancer 100(1):44\u201352","journal-title":"Cancer"},{"issue":"8","key":"348_CR4","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/cncr.21359","volume":"104","author":"A Gennari","year":"2005","unstructured":"Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P (2005) Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104(8):1742\u20131750","journal-title":"Cancer"},{"issue":"1","key":"348_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/1097-0142(19920701)70:1<129::AID-CNCR2820700122>3.0.CO;2-Y","volume":"70","author":"CL Vogel","year":"1992","unstructured":"Vogel CL, Azevedo S, Hilsenbeck S, East DR, Ayub J (1992) Survival after first recurrence of breast cancer. The Miami experience. Cancer 70(1):129\u2013135","journal-title":"Cancer"},{"key":"348_CR6","doi-asserted-by":"crossref","unstructured":"Carrick S, Parker S, Wilcken N, Ghersi D, Marzo M, Simes J (2005) Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev (2):CD003372","DOI":"10.1002\/14651858.CD003372.pub2"},{"issue":"5","key":"348_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1023\/A:1008236502420","volume":"9","author":"A Goldhirsch","year":"1998","unstructured":"Goldhirsch A, Colleoni M, Coates AS, Castiglione-Gertsch M, Gelber RD (1998) Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG). Ann Oncol 9(5):489\u2013493","journal-title":"Ann Oncol"},{"issue":"4","key":"348_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1081\/CNV-120002147","volume":"20","author":"P Kuriakose","year":"2002","unstructured":"Kuriakose P, Gandara DR, Perez EA (2002) Phase I trial of edatrexate in advanced breast and other cancers. Cancer Invest 20(4):473\u2013479","journal-title":"Cancer Invest"},{"issue":"5","key":"348_CR9","first-page":"551","volume":"69","author":"FA Schmid","year":"1985","unstructured":"Schmid FA, Sirotnak FM, Otter GM, DeGraw JI (1985) New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice. Cancer Treat Rep 69(5):551\u2013553","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"348_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.1988.6.3.446","volume":"6","author":"KY Shum","year":"1988","unstructured":"Shum KY, Kris MG, Gralla RJ, Burke MT, Marks LD, Heelan RT (1988) Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer. J Clin Oncol 6(3):446\u2013450","journal-title":"J Clin Oncol"},{"issue":"6","key":"348_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF00685598","volume":"30","author":"RL Souhami","year":"1992","unstructured":"Souhami RL, Rudd RM, Spiro SG, Allen R, Lamond P, Harper PG (1992) Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer. Cancer Chemother Pharmacol 30(6):465\u2013468","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"348_CR12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/oxfordjournals.annonc.a058258","volume":"3","author":"JH Schornagel","year":"1992","unstructured":"Schornagel JH, van der Vegt S, Verweij J, de Graeff A, Dullemond-Westland A, van Deijk WA, ten Bokkel Huinink WW (1992) Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer. Ann Oncol 3(7):549\u2013552","journal-title":"Ann Oncol"},{"issue":"7","key":"348_CR13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1200\/JCO.1993.11.7.1241","volume":"11","author":"TA Vandenberg","year":"1993","unstructured":"Vandenberg TA, Pritchard KI, Eisenhauer EA, Trudeau ME, Norris BD, Lopez P, Verma SS, Buckman RA, Muldal A (1993) Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. J Clin Oncol 11(7):1241\u20131244","journal-title":"J Clin Oncol"},{"issue":"3","key":"348_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/annonc\/mdh097","volume":"15","author":"ME O\u2019Brien","year":"2004","unstructured":"O\u2019Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback DG, Tomczak P, Ackland SP, et al (2004) Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15(3):440\u2013449","journal-title":"Ann Oncol"},{"issue":"10","key":"348_CR15","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.1995.13.10.2575","volume":"13","author":"AD Seidman","year":"1995","unstructured":"Seidman AD, Tiersten A, Hudis C, Gollub M, Barrett S, Yao TJ, Lepore J, Gilewski T, Currie V, Crown J et al (1995) Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol 13(10):2575\u20132581","journal-title":"J Clin Oncol"},{"issue":"4 Suppl 13","key":"348_CR16","first-page":"S13","volume":"24","author":"V Valero","year":"1997","unstructured":"Valero V (1997) Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy. Semin Oncol 24(4 Suppl 13):S13-11\u2013S13\u201318","journal-title":"Semin Oncol"},{"issue":"3","key":"348_CR17","first-page":"501","volume":"7","author":"SA Laurie","year":"2001","unstructured":"Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski G, Pisters KM, Heelan RT, Sirotnak FM (2001) Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin. Clin Cancer Res 7(3):501\u2013509","journal-title":"Clin Cancer Res"},{"issue":"2","key":"348_CR18","first-page":"275","volume":"5","author":"G D\u2019Andrea","year":"1999","unstructured":"D\u2019Andrea G, Fennelly D, Norton L, Baselga J, Gilewski T, Hudis C, Moynahan ME, Raptis G, Sklarin N, Surbone A, et al (1999) Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer. Clin Cancer Res 5(2):275\u2013279","journal-title":"Clin Cancer Res"},{"issue":"1","key":"348_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s002800050710","volume":"41","author":"DR Gandara","year":"1997","unstructured":"Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB (1997) Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study. Cancer Chemother Pharmacol 41(1):75\u201378","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"348_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1023\/A:1026404812699","volume":"10","author":"JR Rigas","year":"1999","unstructured":"Rigas JR, Kris MG, Miller VA, Pisters KM, Heelan RT, Grant SC, Fennelly DW, Chou TC, Sirotnak FM (1999) Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors. Ann Oncol 10(5):601\u2013603","journal-title":"Ann Oncol"},{"issue":"31","key":"348_CR21","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2174\/1381612033453712","volume":"9","author":"JJ McGuire","year":"2003","unstructured":"McGuire JJ (2003) Anticancer antifolates: current status and future directions. Curr Pharm Des 9(31):2593\u20132613","journal-title":"Curr Pharm Des"},{"issue":"9","key":"348_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","volume":"22","author":"N Hanna","year":"2004","unstructured":"Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T et al (2004) Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22(9):1589\u20131597","journal-title":"J Clin Oncol"},{"issue":"8","key":"348_CR23","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1200\/JCO.2003.06.122","volume":"21","author":"GV Scagliotti","year":"2003","unstructured":"Scagliotti GV, Shin DM, Kindler HL, Vasconcelles MJ, Keppler U, Manegold C, Burris H, Gatzemeier U, Blatter J, Symanowski JT et al (2003) Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 21(8):1556\u20131561","journal-title":"J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-006-0348-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0348-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:16:31Z","timestamp":1652814991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-006-0348-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1007\/s00280-006-0348-9","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,29]]},"assertion":[{"value":"5 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}